234 related articles for article (PubMed ID: 18422682)
1. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis.
Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
Dev Med Child Neurol; 2008 Jun; 50(6):450-5. PubMed ID: 18422682
[TBL] [Abstract][Full Text] [Related]
2. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS;
Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up on continuous intrathecal Baclofen therapy in non-ambulant children with intractable spastic Cerebral Palsy.
Vles GF; Soudant DL; Hoving MA; Vermeulen RJ; Bonouvrié LA; van Oostenbrugge RJ; Vles JS
Eur J Paediatr Neurol; 2013 Nov; 17(6):639-44. PubMed ID: 23871360
[TBL] [Abstract][Full Text] [Related]
6. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.
Krach LE; Kriel RL; Day SM; Strauss DJ
Dev Med Child Neurol; 2010 Jul; 52(7):672-6. PubMed ID: 19811519
[TBL] [Abstract][Full Text] [Related]
7. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
Brochard S; Remy-Neris O; Filipetti P; Bussel B
Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
[TBL] [Abstract][Full Text] [Related]
9. Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy.
Bleyenheuft C; Filipetti P; Caldas C; Lejeune T
Neurophysiol Clin; 2007; 37(1):23-8. PubMed ID: 17418354
[TBL] [Abstract][Full Text] [Related]
10. Upper limb function after intrathecal baclofen treatment in children with cerebral palsy.
Motta F; Stignani C; Antonello CE
J Pediatr Orthop; 2008; 28(1):91-6. PubMed ID: 18157052
[TBL] [Abstract][Full Text] [Related]
11. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
Morton RE; Gray N; Vloeberghs M
Dev Med Child Neurol; 2011 Aug; 53(8):736-41. PubMed ID: 21707598
[TBL] [Abstract][Full Text] [Related]
12. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales.
Motta F; Stignani C; Antonello CE
J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
[TBL] [Abstract][Full Text] [Related]
14. The effect of continuous intrathecal baclofen therapy on ambulatory children with cerebral palsy.
Pruszczynski B; Sees J; Hulbert R; Church C; Henley J; Niiler T; Miller F
J Pediatr Orthop B; 2018 May; 27(3):214-220. PubMed ID: 28379909
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
[TBL] [Abstract][Full Text] [Related]
16. Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia.
Motta F; Antonello CE; Stignani C
J Pediatr Orthop; 2009; 29(7):817-21. PubMed ID: 20104168
[TBL] [Abstract][Full Text] [Related]
17. GMFM 1 year after continuous intrathecal baclofen infusion.
Krach LE; Kriel RL; Gilmartin RC; Swift DM; Storrs BB; Abbott R; Ward JD; Bloom KK; Brooks WH; Madsen JR; McLaughlin JF; Nadell JM
Pediatr Rehabil; 2005; 8(3):207-13. PubMed ID: 16087555
[TBL] [Abstract][Full Text] [Related]
18. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
Sampson FC; Hayward A; Evans G; Morton R; Collett B
J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
20. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy.
McCoy AA; Fox MA; Schaubel DE; Ayyangar RN
Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
